A single-arm, open-label phase II clinical trial of SHR-1210 (camrelizumab) in combination with nimotuzumab in the second-line treatment of advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Wang, Feng
Xia, Jin
Meng, Xiangrui
Ji, Yinghua
Yang, Xiuli
Hong, Yong-Gui
Wang, Junsheng
Cui, Donghai
Luo, Zhiquan
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp 1, Henan Canc Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[2] Anyang Tumor Hosp, Anyang, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Med Oncol, Zhengzhou, Peoples R China
[4] Xinxiang Med Univ, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China
[5] Nanyang Med Coll, Affiliated Hosp 1, Nanyang, Peoples R China
[6] Anyang Tumor Hosp, Dept Oncol, Anyang, Henan, Peoples R China
[7] Xinyang Tumor Hosp, Xinyang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16007
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Camrelizumab combined with albumin paclitaxel and platinum in perioperative treatment of resectable squamous cell lung cancer: A single-arm, open-label, phase II clinical trial
    Zhang, Y.
    Liu, S.
    Yang, L.
    Liu, Y.
    Wang, C.
    Han, Y.
    Xiao, B.
    Yan, D.
    Gong, C.
    Wang, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S978 - S978
  • [22] Neoadjuvant camrelizumab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, open-label study
    Wang, Jianping
    Zhang, Jian
    Gao, Jie
    Zhao, Mengmeng
    Ma, Zhenkai
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (06): : 573 - 581
  • [23] A Single-arm, Multicenter, Open-label Phase 2 Study of Lapatinib as the Second-line Treatment of Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma
    Wuelfing, Christian
    Machiels, Jean-Pascal H.
    Richel, Dirk J.
    Grimm, Marc-Oliver
    Treiber, Uwe
    De Groot, Marco R.
    Beuzeboc, Philippe
    Parikh, Roma
    Petavy, Frank
    El-Hariry, Iman A.
    CANCER, 2009, 115 (13) : 2881 - 2890
  • [24] Fruquintinib plus camrelizumab combined with paclitaxel liposome and nedaplatin as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II clinical trial
    Qiu, Tianzhu
    Mingjie, Lu
    Dong, Yuwen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 445 - 445
  • [25] Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
    Zhao, Wensi
    Ke, Shaobo
    Cai, Xiaojun
    Zuo, Zhigang
    Shi, Wei
    Qiu, Hu
    Cai, Gaoke
    Gong, Yi
    Wu, Yong
    Ruan, Shasha
    Chen, Yongshun
    RADIOTHERAPY AND ONCOLOGY, 2023, 184
  • [26] Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: A single-arm, open-label, phase 2 trial
    Wei, Zhigong
    Zhu, Yuchun
    Cai, Lei
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Apatinib plus camrelizumab in patients with advanced cervical cancer: A multicentre, open-label, single-arm, phase II trial
    Huang, X.
    Shen, J.
    Xiong, Y.
    Wang, Y.
    Cao, X.
    He, M.
    Zou, G.
    Deng, Y.
    Wang, X.
    Lan, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 43 - 43
  • [28] Camrelizumab plus chemotherapy combined with consolidative radiotherapy as first-line treatment for oligometastatic esophageal squamous cell carcinoma (ESCORT-1ST-RT): A single-arm, open-label, phase II trial
    Huang, W.
    Han, D.
    Li, B.
    Dong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S902 - S902
  • [29] Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
    Fang, Wenfeng
    Yang, Yunpeng
    Ma, Yuxiang
    Hong, Shaodong
    Lin, Lizhu
    He, Xiaohui
    Xiong, Jianping
    Li, Ping
    Zhao, Hongyun
    Huang, Yan
    Zhang, Yang
    Chen, Likun
    Zhou, Ningning
    Zhao, Yuanyuan
    Hou, Xue
    Yang, Qing
    Zhang, Li
    LANCET ONCOLOGY, 2018, 19 (10): : 1338 - 1350
  • [30] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
12345